SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-017837
Filing Date
2024-06-21
Accepted
2024-06-21 16:20:16
Documents
1
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 form4-06212024_040605.html 4  
1 form4-06212024_040605.xml 4 4002
  Complete submission text file 0001415889-24-017837.txt   5466
Mailing Address C/O RECEPTOS, INC. 10835 ROAD TO THE CURE, SUITE 205 SAN DIEGO CA 92121
Business Address
COOPER GRAHAM K (Reporting) CIK: 0001396943 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38542 | Film No.: 241060688

Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Issuer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)